Public
IR Materials

IR Library

[Analyst Report] Focus on where it is headed, not where it is now Apr 29, 2022
[Analyst Report] Bags major oligonucleotide drug deal Mar 21, 2022
[Analyst Report] Slips to operating loss due to costs, deferred oligo sales Feb 28, 2022
[Analyst Report] Aggressive capex to cement position as global CMO Dec 2, 2021
[Analyst Report] Growing oligo sales proven to boost profits Oct 29, 2021
[Analyst Report] Developing a COVID-19 mRNA vaccine Jul 23, 2021
4of3
HOMEPublicIR (Investor Relations)IR LibraryIR Materials
© 2026 ST Pharm. All rights reserved.

We care about your privacy

This site uses essential cookies necessary for the operation of the service and for maintaining your language preferences. For more information, please review our Privacy Policy and Terms of Service.